Dr. Amit Bhoil
Sr. Consultant – Nuclear Medicine & PET CT
MBBS, MD, EMBA (Healthcare)

Speciality

Oncology

Brief Profile

Dr Amit Bhoil is a highly regarded Sr. Consultant in Nuclear Medicine & PET CT at Holy Family Hospital, Delhi, with more than 14 years of experience at national and international oncology centres. He is interested in Value-based healthcare and personalized nuclear oncology to optimize clinical outcomes.


Education

  • MD (Nuclear Medicine) – Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh
  • • Fellow (Theranostics & PET) – Peter MacCallum Cancer Centre, Melbourne, Australia
  • • Fellow (Nuclear Oncology) – Royal Liverpool University NHS Hospital Trust, UK
  • Clinical Fellow (Nuclear Medicine & PET CT) – Royal Liverpool University NHS Hospital Trust, UK
  • Executive MBA (Healthcare) - Indian School of Business (ISB), Hyderabad.
     

Specialization & Expertise

PET/CT (Positron Emission Tomography Computed Tomography)

SPECT/CT (Single Photon Emission Computed Tomography CT)

Molecular Imaging in Oncology, Neurology and Cardiology.

  • Oncological Imaging (Staging, Restaging, Disease Response Assessment in Cancer)
  • Dementia and Parkinson’s Spectrum Imaging
  • Cardiac PET Imaging (Myocardial Perfusion, Viability, Sarcoidosis)
  • Molecular Imaging for Infection & Inflammation

Radionuclide Therapies and Theranostics:

  • Radioiodine Therapy for Thyroid Disorders (Hyperthyroidism, Thyroid Cancer)
  • Peptide Receptor Radionuclide Therapy (PRRT) for Neuroendocrine Tumours and Prostate Cancer.
  • Radionuclide therapies (Samarium; Radium) for Bone Metastases.
  • Novel Targeted Radiopharmaceuticals for Precision Oncology (Alpha therapy: Actinium; Terbium)

Awards & Achievements

Recipient of multiple academic grants and awards from the Government of India (DST/ICMR) and SNMMI (USA & Europe) for presenting nuclear oncology research at international conferences.


Research & Publications

Dr Amit Bhoil has published various papers and research articles in reputed national and international medical journals, contributing valuable insights to the field of Nuclear Oncology.